U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Devices and Radiological Health
  5. CDRH Offices
  6. OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality
  1. CDRH Offices

OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality


Who We Are

The Office of Health Technology 2 within CDRH's Office of Product Evaluation and Quality (OPEQ) is responsible for the total life cycle (TPLC) review of cardiovascular devices.

What We Do

For cardiovascular devices we:

  •  Implement a TPLC model for the office's medical device product area.  The TPLC model includes implementation of premarket review programs (e.g., 510(k), PMA, HDE, DeNovo, IDE, etc.), compliance and quality programs (e.g., Establishment Inspection Report, Regulatory Audit Reports, Recalls, Allegations of Regulatory Misconduct, Labeling, Enforcement Actions, etc.), and surveillance programs (e.g., Medical Device Reports, Post Market Surveillance Studies, Safety Signals, etc.).
  • Serve as the primary source for scientific and medical expertise with regard to safety and effectiveness of medical devices throughout the total product lifecycle.
  • Work closely with other offices on classification and reclassification activities, and the development of guidance documents.
  • Provide initial support for questions related to regulatory programs in response to requests from medical device and health technology industries, trade associations, other Federal agencies, other countries, State agencies, and the general public.
  • Advise, coordinate, and provide consultation to the OPEQ Director and other Agency officials on Office programs and policies concerning premarket review activities, compliance and quality, and postmarket surveillance activities.
  • Participate in the development of national and international consensus standards, and voluntary guidelines through interaction with national and international standards committees.

Office Organization

Who We Are

The Division of Health Technology 2A within the Office of Health Technology 2 is responsible for the total lifecycle (TPLC) review of cardiac electrophysiology, diagnostics, and monitoring devices.

What We Do

For cardiac electrophysiology, diagnostics and monitoring medical devices:

  • Coordinate, carry out, and make premarket review determinations (e.g., 510(k), PMA, HDE, DeNovo, IDE, etc.).
  • Coordinate, carry out and make postmarket compliance and quality determinations (e.g., Establishment Inspection Report, Regulatory Audit Reports, Recalls, Allegations of Regulatory Misconduct, Labeling, Enforcement Actions, etc.).
  • Coordinate, carry out, and make postmarket surveillance determinations (e.g., Medical Device Reports, Post Market Surveillance Studies, Safety Signals, etc.).
  • Participate in development and interpretation of regulations and policies.
  • Coordinate actions on classification.
  • Review and evaluate design, test, and production data and reports from manufacturers to ensure compliance with promulgated standards and regulations.
Who We Are

The Division of Health Technology 2B within the Office of Health Technology 2 is responsible for the total lifecycle (TPLC) review of circulatory support, structural and vascular devices.  

What We Do

For circulatory support, structural and vascular devices, we:

  • Coordinate, carry out, and make premarket review determinations (e.g., 510(k), PMA, HDE, DeNovo, IDE, etc.).
  • Coordinate, carry out and make postmarket compliance and quality determinations (e.g., Establishment Inspection Report, Regulatory Audit Reports, Recalls, Allegations of Regulatory Misconduct, Labeling, Enforcement Actions, etc.).
  • Coordinate, carry out, and make postmarket surveillance determinations (e.g., Medical Device Reports, Post Market Surveillance Studies, Safety Signals, etc.).
  • Participate in development and interpretation of regulations and policies.
  • Coordinate actions on classification.
  • Review and evaluate design, test, and production data and reports from manufacturers to ensure compliance with promulgated standards and regulations.
Who We Are

The Division of Health Technology 2C within the Office of Health Technology 2 is responsible for the total lifecycle (TPLC) review of coronary and peripheral intervention devices.

What We Do

For coronary and peripheral intervention devices, we:

  • Coordinate, carry out, and make premarket review determinations (e.g., 510(k), PMA, HDE, DeNovo, IDE, etc.).
  • Coordinate, carry out and make postmarket compliance and quality determinations (e.g., Establishment Inspection Report, Regulatory Audit Reports, Recalls, Allegations of Regulatory Misconduct, Labeling, Enforcement Actions, etc.).
  • Coordinate, carry out, and make postmarket surveillance determinations (e.g., Medical Device Reports, Post Market Surveillance Studies, Safety Signals, etc.).
  • Participate in development and interpretation of regulations and policies.
  • Coordinate actions on classification.
  • Review and evaluate design, test, and production data and reports from manufacturers to ensure compliance with promulgated standards and regulations.

Contact Us

For specific phone numbers and email addresses for each office, see the CDRH Management Directory by Organization.

For general questions about medical devices regulation, contact the Division of Industry and Consumer Education at dice@fda.hhs.gov or 800.638.2041 or 301.796.7100.




Back to Top